CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.

about

Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.Prognostic value of CD44v6 expression in breast cancer: a meta-analysis

P2860

Q42371513-9E12B215-4CDD-4BA0-AA3D-294E4188D246 Q55309145-FA903316-B534-41B7-94A9-BD38047CED0B Q58764989-9EE5A713-AE97-4905-ABA7-202998A69383

P2860

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.

Item

http://www.wikidata.org/entity/Q43376023

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@en

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@nl

type

Item

label

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@en

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@nl

prefLabel

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@en

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@nl

P1476

CD44v6-Targeted Imaging of Hea ...... ma: Antibody-Based Approaches.

@en

P275

Creative Commons Attribution 4.0 International

P2860

Alternative molecular formats and therapeutic applications for bispecific antibodies

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

TNM staging of cancers of the head and neck: striving for uniformity among diversity.

Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.

HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems.

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

P304

2709547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2017/2709547

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Johan Nilvebrant

Diana Spiegelberg

P5008

ScienceSource

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29097914

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

head and neck cancer

cell surface receptor

membrane proteins

squamous cell carcinoma

P932

5612744

http://www.w3.org/2001/XMLSchema#string

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.

about

P2860

P2860

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.

description

name

type

label

prefLabel

P1433

P1476

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932